Skip to main content
Signal8

Ainsworth Sean

SEC insider (Form 3/4/5 filer). CIK 0001830296. Director at Opus Genetics, Inc. (IRD). 4 reported Form 4/5 transactions since Sep 2024; latest on Apr 20, 2026. Located in DURHAM, NC.

Companies Ainsworth Sean has filed insider reports for

  • Opus Genetics, Inc. (IRD): Director
Ainsworth Sean profile photo

Ainsworth Sean

CIK: 0001830296

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Opus Genetics, Inc. logo
IRD

Opus Genetics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Opus Genetics, Inc. logo
    IRD

    Opus Genetics, Inc.

    Apr 20, 2026
    Award
    Direct
    24.4K shares-
  • Opus Genetics, Inc. logo
    IRD

    Opus Genetics, Inc.

    Jan 1, 2026
    Award
    Direct
    42.5K shares-
  • Opus Genetics, Inc. logo
    IRD

    Opus Genetics, Inc.

    Aug 25, 2025
    Award
    Direct
    87K shares at avg. $1.15$100K
  • Opus Genetics, Inc. logo
    IRD

    Opus Genetics, Inc.

    Apr 30, 2025
    Award
    Direct
    79.5K shares-

1-4 of 4